CYB003-001
Showing 26 - 50 of 3,080
COVID-19 Vaccine Trial in Sydney (EG-COVID-003, EG-COVID-001)
Recruiting
- COVID-19 Vaccine
-
Sydney, New South Wales, AustraliaHoldsworth House
Jul 27, 2022
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Influenza Trial in Manila, Quezon City (Fluzone Quadrivalent Influenza Vaccine)
Completed
- Influenza
- Fluzone Quadrivalent Influenza Vaccine
-
Manila, Philippines
- +2 more
Mar 15, 2022
NSCLC Trial in Salvador, Belo Horizonte, São Paulo
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Salvador, Bahia, Brazil
- +3 more
Nov 28, 2022
Advanced Solid Tumor, Lymphoma Trial in Australia, United States (ALPN-202)
Active, not recruiting
- Advanced Solid Tumor
- Lymphoma
-
Scottsdale, Arizona
- +9 more
Nov 8, 2022
Influenza, Flu Trial in Council Bluffs, Bardstown, Metairie (Fluzone Quadrivalent vaccine, Fluzone High-Dose vaccine)
Completed
- Influenza
- Flu
- Fluzone Quadrivalent vaccine
- Fluzone High-Dose vaccine
-
Council Bluffs, Iowa
- +2 more
Mar 15, 2022
Low Back Pain Trial in Worldwide (Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005)
Completed
- Low Back Pain
- Matching Placebo
- +4 more
-
Senftenberg, Austria
- +78 more
Jul 13, 2021
NSCLC Trial (Cemiplimab)
Recruiting
- Non-small Cell Lung Cancer
-
Konstanz, Baden-Württemberg, Germany
- +8 more
Jan 6, 2023
Pain, Tumors, Chronic Pain Trial in Worldwide (Cebranopadol, Morphine Prolonged Release)
Terminated
- Pain
- +2 more
- Cebranopadol
- Morphine Prolonged Release
-
Vienna, Austria
- +41 more
Jul 13, 2021
Melanoma Trial in Belgium, Spain (ECI-006)
Terminated
- Melanoma
- ECI-006
-
Antwerpen, Belgium
- +8 more
Jun 16, 2021
Chronic Pain, Diabetic Neuropathies, Diabetes Trial in Worldwide (Cebranopadol 100 µg, Cebranopadol 300 µg, Cebranopadol 600 µg)
Completed
- Chronic Pain
- +2 more
- Cebranopadol 100 µg
- +4 more
-
Mesa, Arizona
- +81 more
Jul 13, 2021
COMP 001 And COMP 003 Trials (P-TRD LTFU)
Recruiting
- Treatment Resistant Depression
-
La Jolla, California
- +7 more
Mar 2, 2021
Study on Patterns of Care in Mild Asthmatic Patients
Completed
- Asthma
-
Berlin, Germany
- +58 more
Sep 26, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Malaysia (CYD Dengue Vaccine, Human Papillomavirus
Completed
- Dengue Fever
- +2 more
- CYD Dengue Vaccine
- Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.
-
Klang, Malaysia
- +4 more
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (CYD Dengue Vaccine (5-dose formulation), Placebo, NaCl 0.9%)
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- CYD Dengue Vaccine (5-dose formulation)
- Placebo, NaCl 0.9%
-
Vitoria, Brazil
- +4 more
Mar 15, 2022
Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in Finland (Meningococcal Polysaccharide (Serogroups A, C,
Completed
- Meningitis
- +2 more
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
- Meningococcal Polysaccharide groups A, C, W-135 and Y Conjugate Vaccine
-
Espoo, Finland
- +7 more
Mar 24, 2022
Vaginal Disease Trial in France (Mucogyne® ovule)
Active, not recruiting
- Vaginal Disease
- Mucogyne® ovule
-
Besançon, France
- +6 more
Dec 13, 2021
Psoriasis Trial in United States (Brodalumab)
Recruiting
- Psoriasis
- Brodalumab
-
San Diego, California
- +4 more
Sep 29, 2021
ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Inclisiran Sodium)
Active, not recruiting
- ASCVD
- +3 more
- Inclisiran Sodium
-
Birmingham, Alabama
- +237 more
Jan 26, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Pembrolizumab
- +2 more
-
Anchorage, Alaska
- +162 more
Aug 23, 2022